22 Nw, LP Lian Bio Transaction History

22 Nw, LP

  • $88.5 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$1.49 - $2.46 $3.08 Million - $5.09 Million
2,070,455 Added 1466.09%
2,211,678 $3.3 Million
Q2 2022

Aug 12, 2022
BUY
$2.15 - $6.01 $303,629 - $848,750
141,223 New
141,223 $305,000

Others Institutions Holding LIAN

# of Institutions
3
Shares Held
1.1M
Call Options Held
0
Put Options Held
0
View Full List

About LianBio

LIAN Quotes by TradingView
  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $32.5M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track 22 Nw, LP Portfolio

Follow 22 Nw, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 22 Nw, LP, based on Form 13F filings with the SEC.

News

Stay updated on 22 Nw, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email